Crane NXT vs Novanta
Add, change or remove companies; up to four.
The short version
- Crane NXT is the larger business, with $1.7B of revenue in fiscal 2025 against $981M for Novanta, about 1.7 times as much.
- Crane NXT grew revenue faster (11.4%, against 3.3%).
- Crane NXT kept more of each dollar of sales as operating profit (14.9% operating margin, against 9.6%).
- Crane NXT turned more of its sales into free cash flow (12.0% FCF margin, against 4.9%).
- Crane NXT earned a higher return on the capital invested in it (10.4%, against 6.5%).
- Investors pay more for each dollar of Novanta’s earnings: a P/E of 89.7x against 23.6x for Crane NXT.
| Latest fiscal year | CXT · FY25 | NOVT · FY25 |
|---|---|---|
| Size | ||
| Market cap | $3.3B | $5.8B |
| Revenue | $1.7B | $981M |
| Free cash flow | $198M | $48.4M |
| Net income | $145M | $53.8M |
| Growth | ||
| Revenue growth | 11.4% | 3.3% |
| 5-year growth | — | 10.7% |
| Share count change | 0.4% | 1.6% |
| Profitability | ||
| Gross margin | 42.5% | 44.4% |
| Operating margin | 14.9% | 9.6% |
| Net margin | 8.8% | 5.5% |
| FCF margin | 12.0% | 4.9% |
| Return on capital | 10.4% | 6.5% |
| Return on equity | 12.5% | 5.2% |
| Balance sheet | ||
| Net debt | $906M | −$127M |
| Net debt / EBITDA | 2.6x | −0.8x |
| Dividends and buybacks | $39.0M | $39.3M |
| Valuation & quality | ||
| P/E | 23.6x | 89.7x |
| Piotroski F-score | 4 | 5 |
Revenue
FY16
CXT —
NOVT $385M
FY17
CXT —
NOVT $521M
FY18
CXT —
NOVT $614M
FY19
CXT —
NOVT $626M
FY20
CXT —
NOVT $591M
FY21
CXT —
NOVT $707M
FY22
CXT —
NOVT $861M
FY23
CXT $1.4B
NOVT $882M
FY24
CXT $1.5B
NOVT $949M
FY25
CXT $1.7B
NOVT $981M
CXT
NOVT
Operating margin
FY16
CXT —
NOVT 8.6%
FY17
CXT —
NOVT 11.0%
FY18
CXT —
NOVT 11.6%
FY19
CXT —
NOVT 8.8%
FY20
CXT —
NOVT 9.5%
FY21
CXT —
NOVT 9.1%
FY22
CXT —
NOVT 12.0%
FY23
CXT 20.6%
NOVT 12.5%
FY24
CXT 18.1%
NOVT 11.7%
FY25
CXT 14.9%
NOVT 9.6%
CXT
NOVT
Free cash flow
FY16
CXT —
NOVT $39.3M
FY17
CXT —
NOVT $54.3M
FY18
CXT —
NOVT $75.0M
FY19
CXT —
NOVT $52.5M
FY20
CXT —
NOVT $130M
FY21
CXT —
NOVT $74.7M
FY22
CXT —
NOVT $71.1M
FY23
CXT $245M
NOVT $100M
FY24
CXT $169M
NOVT $141M
FY25
CXT $198M
NOVT $48.4M
CXT
NOVT
Return on capital
FY16
CXT —
NOVT 8.1%
FY17
CXT —
NOVT 13.2%
FY18
CXT —
NOVT 12.6%
FY19
CXT —
NOVT 9.2%
FY20
CXT —
NOVT 9.0%
FY21
CXT —
NOVT 8.1%
FY22
CXT —
NOVT 9.9%
FY23
CXT —
NOVT 10.4%
FY24
CXT 14.4%
NOVT 9.1%
FY25
CXT 10.4%
NOVT 6.5%
CXT
NOVT
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.